Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model
about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsCorrelation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein bindingHigh protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulationEfficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes.Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MICNo Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.Resistance to antimicrobial agents: an update.High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase.Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.Rifampin combination therapy for nonmycobacterial infections.Protein binding: do we ever learn?Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?Protein binding and antimicrobial activity of ceftriaxone: comparative assessments by gradient plate technique and time-kill study.Seventy-five years of research on protein binding - do we ever understand?Associations between resistance phenotype and gene expression in response to serial exposure to oxacillin and ciprofloxacin in Staphylococcus aureus.study of new combinations for local antibiotic therapy with calcium sulphate - Near constant release of ceftriaxone offers new treatment options
P2860
Q26827380-046A360A-7D50-49BA-9CA5-C8431C8FE321Q28353204-F2EC6B45-CACE-4478-B891-10AFD7AE8384Q28473173-D4BB2708-2E66-422C-8643-FA16FDBF4A03Q33704139-10999BAF-277D-4721-A689-85277D5D7682Q35130345-BEFC914F-7D33-43B1-AEFA-6FD5600F978FQ35637864-EF2E6A2D-B2B9-43F4-B643-7945FD3906ACQ35785093-71EBB8CC-E17B-4C80-BA75-78D5F87B1903Q35976850-F9E44BE0-5396-4B95-BA25-A8EBCC94AC58Q36670187-621A97DD-D9FA-4273-840E-6A680A2E99FEQ37144963-D3AA01B0-6A53-4BE1-9F06-806B017A6515Q37149078-06D36391-BCB3-4763-8CAD-28E7C3DF240CQ37672039-1939B8F0-024B-4CD7-AF98-5E4864AF010BQ37871252-D5A48B9F-45C6-4693-B805-06180ED30FB0Q39473401-9C2FDF91-8135-4716-AA68-BF60C01A9E82Q41994740-9C98FA46-0B0C-4079-A2FA-A3B01FD96D8FQ45257437-116B012D-A1F1-43FB-BC49-B08348AAEAB7Q47381610-ED0673A7-A166-4C50-B5DF-19D52E57B889Q47601682-69112AB4-613F-496C-9A23-D8C2FE2C14ACQ58695395-00AB5D57-9AD8-43DF-96A7-0FB572D8AFE1
P2860
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Bactericidal killing activitie ...... in an in vitro infection model
@ast
Bactericidal killing activitie ...... in an in vitro infection model
@en
type
label
Bactericidal killing activitie ...... in an in vitro infection model
@ast
Bactericidal killing activitie ...... in an in vitro infection model
@en
prefLabel
Bactericidal killing activitie ...... in an in vitro infection model
@ast
Bactericidal killing activitie ...... in an in vitro infection model
@en
P2093
P2860
P356
P1476
Bactericidal killing activitie ...... in an in vitro infection model
@en
P2093
P2860
P304
P356
10.1128/AAC.39.8.1764
P407
P577
1995-08-01T00:00:00Z